India's pharma industry shifts to value-driven approaches, focusing on complex generics, innovation, and expanding medical ...

Economic Survey 2025-26: India's pharma industry shifts to value-driven approach, focusing on generics, biosimilars, and ...

The Indian pharmaceutical industry is the world’s third-largest by volume, meeting approximately 20% of global generics demand ...

The day after a major winter storm swept across the U.S., hundreds of thousands of homes and businesses remained without ...

Our Bureau, New Delhi Thursday, January 29, 2026, 16:15 Hrs [IST] ...

India's pharma sector is moving towards high-value products like complex generics and biosimilars. The medical devices ...

Where do markets go in 2026? As in 2025, implied expectations embedded in derivatives-market data have already offered an ...

Read all the key highlights from the economic report card presented by the finance minister Nirmala Sitharaman ahead of Union ...

Industry estimates pegged the sector’s size at around Rs 2.5 trillion in 2024, driven by rising incomes, rapid internet ...

Geopolitical fragmentation in 2025 led to regionalized supply chains, higher costs, and increased geopolitical risks for multinational companies. Despite economic resilience, a deepening K-shaped ...

In an era where sustainability has transitioned from a corporate buzzword to a fundamental business imperative, organisations worldwide are seeking innovative ways to reduce waste, conserve resources, ...

Market valued at $46.59B in 2024, projected 7.31% CAGR growth driven by bio-based adoption, detergent demand, and ...